Antibody–drug conjugates in lung and breast cancer: current evidence and future directions—a position statement from the ETOP IBCSG Partners Foundation
Solange Peters, Sherene Loi, Fabrice André, Sarat Chandarlapaty, Enriqueta Felip, Stephen P. Finn, Pasi A. Jänne, Keith M. Kerr, Elisabetta Munzone, Antonio Passaro, M. Pérol, Egbert F. Smit, Charles Swanton, Giuseppe Viale, Rolf A. Stahel
Topics & Concepts
MedicinePosition statementFoundation (evidence)AntibodyStatement (logic)Lung cancerDrugAntibody-drug conjugateBreast cancerCancerVirologyImmunologyOncologyInternal medicineFamily medicinePharmacologyMonoclonal antibodyArchaeologyPolitical scienceHistoryLawHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchLung Cancer Treatments and Mutations